Corporate Support
Sitemap

Features

Customer Services

Events

Terms of Use

Singapore
Malaysia

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,472.3
21.5 (0.88%)

 

  • STI Straits Times Index
    2,472.3
    21.5 (0.88%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,509.1
    8.3 (0.56%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,235.4
    -75.7 (-0.32%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,219.4
    -3.8 (-0.12%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,204.6
    116.8 (0.51%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,945.8
    103.0 (2.13%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,059.2M
  • Value: 869.4M
  • Rise: 172
  • Fall: 134
  • Unch: 475

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol

  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Jiutian Chemical0.051+0.005
Sembcorp Marine0.142-0.002
Alset0.062-0.001
Samko Timber0.034+0.001
Avarga0.260+0.015
AnAn Intl0.033+0.004
Addvalue Tech0.024+0.001
Rex Intl0.146+0.003
Singtel2.140+0.020
ThaiBev0.585-

World Indices

World Indices
Name Last Change
Nasdaq 10,672.3 +39.3
HSI 23,235.4 -75.7
HSCEI 9,302.6 -68.6
Jakarta 4,945.8 +103.0
Nikkei 225 23,204.6 +116.8
SSE Comp 3,219.4 -3.8
Shanghai A 3,374.1 -4.0
Shanghai B 247.4 +0.8
KOSPI 2,278.8 +6.1

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help

  • Factsheet

  • Print

Medtecs Intl MEDTECS INTERNATIONAL CORP LTD
Quotes 10 Minutes Delayed. Updated at 25 Sep 2020 17:15
Last (SGD): 1.220 Change: -0.010 High: 1.270 Remarks: -
Change (%): -0.81 Low: 1.210
Open 1.230 Yesterday's Close 1.230
Buy Price 1.210 Sell Price 1.220
Buy Volume ('000) 596.3 Sell Volume ('000) 27.5
Cumulative Volume ('000) 11,670.6 Cumulative Value 14,452,285
 
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a 0.00285 Trailing EPS (SGD) e 0.10052 NAV (SGD) b 0.2571
PE a 428.070 Trailing PE f 12.137 Price / NAV b 4.7452
Dividend (SGD) d - Cash In Hand (SGD) g 0.0525 Issued & Paid-up Shares c 549,411,000
Dividend Yield (%) d - Price / Cash In Hand g 23.238 Treasury Shares h -
Beta - 75 Daysi 1.333 R-Squared - 75 Days(%)i 4.55 Market Cap (M) 670.281
Beta - 500 Daysi -0.188 R-Squared - 500 Days (%)i 0.02 Enterprise Value (M) 697.984
Piotroski F Score 7 Exchange Code 546 Par Value ( USD ) 0.05000
52 Weeks Volatility (%) 149.4495 6-Month VWAP 0.609 Free Float (%) 100.0
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Manufacturing - Medical Specialties
Category Classification Medical & Biotechnology
Index Components FTSE ST Catalist Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 07 Sep 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Medtecs Intl SGX 670.281 428.070 12.137 4.7452 -
Industry Medical & Biotechnology SGX 932.755 22.016 21.252 1.3270 2.062
Medical Specialties SGX 4,073.003 39.839 36.486 12.9783 1.287
Index FTSE ST Catalist Index SGX 64.946 30.063 88.683 1.1189 1.705
Local Peer Top Glove SGX 23,091.529 38.034 38.033 14.2000 1.356
Local Peer UG Healthcare SGX 520.682 38.850 38.851 7.3009 0.269
Local Peer Biolidics SGX 95.057 - - 8.8235 -
Local Peer Yunnan Energy SGX 43.794 - - 0.9055 -
Local Peer Annica SGX 16.675 - - 5.0000 -
Global Peer ABBOTT LABORATORIES NYSE 183,161.329 49.962 59.603 5.9900 1.270
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 167,053.279 45.198 45.076 5.5917 0.181
Global Peer DANAHER CORP NYSE 146,961.168 59.049 50.310 4.4542 0.322
Global Peer MEDTRONIC PLC NYSE 138,669.735 28.956 31.430 2.7571 2.166
Global Peer INTUITIVE SURGICAL INC NASDAQ 78,843.927 57.162 69.405 9.0205 -
Global Peer STRYKER CORP NYSE 77,002.986 36.967 48.097 6.0376 1.038
Global Peer BECTON DICKINSON & CO NYSE 64,953.846 60.031 83.920 2.7042 1.291
Global Peer BOSTON SCIENTIFIC CORP NYSE 53,421.218 11.366 13.422 3.4209 -
Global Peer EDWARDS LIFESCIENCES CORP NYSE 48,153.840 45.997 64.758 12.5429 -
Global Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 41,070.269 31.443 36.861 3.3388 2.029
Other Global Peers BAXTER INTERNATIONAL INC (NYSE), DEXCOM INC (NASDAQ), IDEXX LABORATORIES INC (NASDAQ), AGILENT TECHNOLOGIES INC (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), ALCON AG (NYSE), ALIGN TECHNOLOGY INC (NASDAQ), RESMED INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), METTLER-TOLEDO INTERNATIONAL INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), COOPER COS INC (NYSE), TOPGLOV (Bursa), HOLOGIC INC (NASDAQ), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), TELEFLEX INC (NYSE), BIO RAD LABORATORIES INC (NYSE), INSULET CORPORATION (NASDAQ), STERIS PLC (NYSE), HARTA (Bursa), PERKINELMER INC (NYSE), FISHER & PAYKEL HEALTHCARE CORP (ASX), MASIMO CORPORATION (NASDAQ), ABIOMED INC (NASDAQ), QIAGEN NV (NYSE), WATERS CORP (NYSE), NOVOCURE LTD (NASDAQ), DENTSPLY SIRONA INC (NASDAQ), COCHLEAR LTD (ASX), WEIGAO GROUP (HKEx), QUIDEL CORP (NASDAQ), PENUMBRA INC (NYSE), MICROPORT (HKEx), TANDEM DIABETES CARE INC (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), BRUKER CORPORATION (NASDAQ), HILL-ROM HOLDINGS INC (NYSE), SUPERMX (Bursa), GLOBUS MED INC (NYSE), NEVRO CORP (NYSE), HAEMONETICS CORP (NYSE), VENUS MEDTECH-B (HKEx), NEOGEN CORP (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), ICU MEDICAL INC (NASDAQ), ENVISTA HOLDINGS CORPORATION (NYSE), INSPIRE MEDICAL SYSTEMS INC (NYSE), KANGJI MEDICAL (HKEx), INARI MEDICAL INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), AK MEDICAL (HKEx), STAAR SURGICAL CO (NASDAQ), NUVASIVE INC (NASDAQ), EBOS GROUP (ASX), SHOCKWAVE MEDICAL INC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), PEIJIA-B (HKEx), CONMED CORP (NYSE), GLAUKOS CORPORATION (NYSE), OUTSET MEDICAL INC (NASDAQ), LIVANOVA PLC (NASDAQ), CANTEL MEDICAL CORP (NYSE), ATRICURE INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), AVANOS MEDICAL INC (NYSE), CAREDX INC (NASDAQ), BIOTELEMETRY INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), INMODE LTD (NASDAQ), NANO-X IMAGING LTD (NASDAQ), MESA LABORATORIES INC (NASDAQ), NANOSONICS LIMITED (ASX), CIRC (HKEx), ATRION CORP (NASDAQ), LIFETECH SCI (HKEx), CERUS CORP (NASDAQ), KDL MEDICAL (HKEx), GENMARK DIAGNOSTICS INC (NASDAQ), HESKA CORP (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), VERICEL CORP (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), CRYOLIFE INC (NYSE), LEMAITRE VASCULAR INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), SI BONE INC (NASDAQ), VAPOTHERM INC (NYSE), INFUSYSTEM HOLDINGS INC (NYSE American), INOGEN INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), ZYNEX INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), SURMODICS INC (NASDAQ), QUOTIENT LTD (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), VIEWRAY INC (NASDAQ), AXOGEN INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), ANTARES PHARMA INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), YESTAR HEALTH (HKEx), ANGIODYNAMICS INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), GOLDEN MEDITECH (HKEx), CUTERA INC (NASDAQ), PROFOUND MED CORP (NASDAQ), CORMEDIX INC (NYSE American), REPRO MEDSYSTEMS INC (NASDAQ), PW MEDTECH (HKEx), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), AROA BIOSURGERY LTD (ASX), IRADIMED CORP (NASDAQ), INVACARE CORP (NYSE), STEREOTAXIS INC (NYSE American), MEDICAL DEVELOPMENT INTL (ASX), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), TELA BIO INC (NASDAQ), ALPHA PRO TECH (NYSE American), ACCURAY INCORPORATED (NASDAQ), DERMTECH INC (NASDAQ), MISONIX INC (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), SIENTRA INC (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), SOLITON INC (NASDAQ), FONAR CORP (NASDAQ), MODERN DENTAL (HKEx), SOLENO THERAPEUTICS INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), ATOMO DIAGNOSTICS LIMITED (ASX), ZOSANO PHARMA CORP (NASDAQ), SOMNOMED LIMITED (ASX), CYCLOPHARM LIMITED (ASX), EMVISION MEDICAL DEVICES LTD (ASX), DARIOHEALTH CORP (NASDAQ), LKL (Bursa), VINCENT MED (HKEx), INTRICOM CORP (NASDAQ), RESPIRI LTD (ASX), CHEMBIO DIAGNOSTICS INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), PAVMED INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), BIOMERICA INC (NASDAQ), ELECTROMED INC (NYSE American), NEURONETICS INC (NASDAQ), VOLITIONRX LIMITED (NYSE American), ROCKWELL MEDICAL INC (NASDAQ), CONFORMIS INC (NASDAQ), ELECTROCORE INC (NASDAQ), YUNNAN ENERGY (HKEx), ENLIVEX THERAPEUTICS LTD (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), SDI LTD (ASX), DAXOR CORP (NYSE American), NEPHROS INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), TITAN MEDICAL INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), NEOVASC INC (NASDAQ), COMPUMEDICS (ASX), APPLIED UV INC (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), MICRO-X LTD (ASX), MILESTONE SCIENTIFIC INC (NYSE American), IMPEDIMED LIMITED (ASX), KELFRED (HKEx), OPTISCAN IMAGING (ASX), SENSUS HEALTHCARE INC (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), RESONANCE HEALTH LTD (ASX), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), ONCOCYTE CORP (NYSE American), IMMUCELL CORP (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), INCANNEX HEALTHCARE LTD (ASX), EKSO BIONICS HOLDINGS INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), NOVA EYE MEDICAL LIMITED (ASX), DIMERIX LTD (ASX), APOLLO ENDOSURGERY INC (NASDAQ), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), MOTUS GI HOLDINGS INC (NASDAQ), LIFE HEALTHCARE (HKEx), CARDIEX LTD (ASX), LBT INNOVATIONS LTD (ASX), AVINGER INC (NASDAQ), IRIDEX CORP (NASDAQ), NEUROTROPE INC (NASDAQ), OVENTUS MEDICAL LTD (ASX), BIOLASE INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), METALICITY LIMITED (ASX), CELSION CORPORATION (NASDAQ), CHF SOLUTIONS INC (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE), USCOM LTD (ASX), HANCOCK JAFFE LABORATORIES INC (NASDAQ), AETHLON MEDICAL INC (NASDAQ), MYOS RENS TECHNOLOGY INC (NASDAQ), CHECK-CAP LTD (NASDAQ), CYANOTECH CORP (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), PREDICTIVE ONCOLOGY INC (NASDAQ), ADHERIUM LIMITED (ASX), DIGIRAD CORP (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), LIANLUO SMART LIMITED (NASDAQ), STHAI (SET), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), CANCER GENETICS INC (NASDAQ), DYNATRONICS CORP (NASDAQ), NANOVIBRONIX INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), ANALYTICA (ASX), OBALON THERAPEUTICS INC (NASDAQ), NEUROMETRIX INC (NASDAQ), HUAKANG BIOMED (HKEx), DORSAVI LTD (ASX), NEUROTECH INTERNATIONAL LTD (ASX), INSPIREMD INC (NYSE American), MEDIGARD LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.150
+14.02 %
10 Days --0.080
-6.15 %
20 Days 0.012-0.300
-18.95 %
Medium Term Return 3 Months 0.012+0.880
+262.35 %
6 Months 0.012+1.146
+1564.86 %
1 Year 0.012+1.190
+4006.67 %
Long Term Return 2 Years 0.012+1.187
+3633.33 %
3 Years 0.012+1.171
+2414.29 %
5 Years 0.012+1.167
+2224.53 %
Annualised Return Annualised --
+87.61 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.027 - 1.980 Change From 1 Year Low +1.193 % Change From 1 Year Low (%) +4418.52
Change From 1 Year High -0.760 % Change From 1 Year High (%) -38.38
2 Years Range 0.022 - 1.980 Change From 2 Years Low +1.198 % Change From 2 Years Low (%) +5445.45
Change From 2 Years High -0.760 % Change From 2 Years High (%) -38.38
5 Years Range 0.022 - 1.980 Change From 5 Years Low +1.198 % Change From 5 Years Low (%) +5445.45
Change From 5 Years High -0.760 % Change From 5 Years High (%) -38.38
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Group's business started in 1989 with the incorporation of Clement Textile & International Corporation in Philippines in 1989. Medtecs is an integrated healthcare product and services provider in Asia Pacific, and a manufacturer and distributor of medical consumables for the healthcare industry. Started in the Philippines in 1989, the Group has established its presence in the United States, Europe and the Asia Pacific region. Today, the Group has offices in Singapore, Hong Kong, Taiwan, the Philippines, Cambodia and China.The Group is an original product manufacturer (OPM) of a wide range of medical consumables for large multinational healthcare distributors, pharmaceutical companies and hospital groups in the United States and Europe. Major product groups manufactured by the Group include linen, hospital apparel, hospital apparel and bandages. The Group’s OPM is supported by 10 manufacturing facilities located in the Philippines (4), China (4) and one each in Cambodia and Taiwan.The Group also acts as agent to distribute other branded medical devices in Asia Paci8fic, including medical supplies and equipment such as wheel chairs, syringes, gauzes, digital thermometers, nebulizers, blood pressure monitors and others.The Group’s Taiwan Depository Receipts (TDR) was listed on the Taiwan Stock Exchange on 13 December 2002.The Company is an investment holding company incorporated in Bermuda on 26 November 1997.

IPO Performance

Listing Date 06 Oct 1999 Full Subscription Rate (x) 10.99
No of Placement Shares (M) 27.00 No of Public Offer Shares (M) 18.00 Public Offer Subscription Rate (x) 25.98
IPO Price (SGD) a 0.251 First Day Close (SGD) a 0.334 First Week Close (SGD) a 0.328
Current vs IPO Price (%) +386.06 First Day Gain (%) +33.07 First Week Gain (%) +30.68
Notes:
  1. Adjusted for the following: Bonus issue 1 for 5 on 29/04/2004

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2019 Dec 2019 Part 1(5.04 MB)
Annual Report 2018 Dec 2018 Part 1(3.96 MB)
Annual Report 2017 Dec 2017 Part 1(3.57 MB)
Part 2(0.45 MB)
Annual Report 2016 Dec 2016 Part 1(2.67 MB)
Annual Report 2015 Dec 2015 Part 1(1.52 MB)
Annual Report 2014 Dec 2014 Part 1(4.00 MB)
Annual Report 2013 Dec 2013 Part 1(3.85 MB)
Annual Report 2012 Dec 2012 Part 1(3.68 MB)
Annual Report 2011 Dec 2011 Part 1(6.92 MB)
Annual Report 2010 Dec 2010 Part 1(3.56 MB)
Annual Report 2009 Dec 2009 Part 1(2.70 MB)
Annual Report 2008 Dec 2008 Part 1(1.48 MB)
Annual Report 2007 Dec 2007 Part 1(3.26 MB)
Part 2(0.02 MB)
Annual Report 2006 Dec 2006 Part 1(7.72 MB)
Annual Report 2005 Dec 2005 Part 1(23.76 MB)
IPO Prospectus
IPO Prospectus 1999 Oct 1999 Part 1(0.12 MB)
Part 2(0.39 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
25 Sep 2020 1.230 1.270 1.210 1.220 11,670,600 1.2383
24 Sep 2020 1.260 1.270 1.210 1.230 18,004,800 1.2456
23 Sep 2020 1.220 1.340 1.200 1.280 55,365,400 1.2673
22 Sep 2020 1.020 1.180 1.000 1.180 46,018,000 1.1025
21 Sep 2020 1.070 1.150 0.975 1.010 35,867,700 1.0360
18 Sep 2020 1.200 1.220 1.020 1.070 33,708,400 1.1265
17 Sep 2020 1.250 1.270 1.180 1.180 13,529,000 1.2166
16 Sep 2020 1.250 1.270 1.180 1.250 15,428,300 1.2298
15 Sep 2020 1.260 1.310 1.240 1.240 10,718,000 1.2723
14 Sep 2020 1.330 1.340 1.260 1.260 10,335,400 1.2885
11 Sep 2020 1.250 1.330 1.170 1.300 20,905,000 1.2841
10 Sep 2020 1.430 1.430 1.220 1.250 20,124,500 1.2826
09 Sep 2020 1.410 1.430 1.350 1.410 9,682,400 1.3909
08 Sep 2020 1.470 1.530 1.430 1.430 26,631,300 1.4821
07 Sep 2020 1.420 1.490 1.410 1.440 20,770,700 1.4462
04 Sep 2020 1.220 1.400 1.190 1.380 33,384,800 1.2931
03 Sep 2020 1.520 1.520 1.280 1.310 28,545,600 1.3854
02 Sep 2020 1.570 1.590 1.490 1.530 13,786,300 1.5328
01 Sep 2020 1.540 1.590 1.530 1.550 14,280,400 1.5615
31 Aug 2020 1.530 1.610 1.520 1.520 21,696,000 1.5623
28 Aug 2020 1.530 1.540 1.490 1.520 8,444,600 1.5191
27 Aug 2020 1.590 1.610 1.460 1.500 15,366,200 1.5155
Summary
Current 2 Weeks
(14 Sep 2020 to 25 Sep 2020)		 1.330 1.340 0.975 1.220 250,645,600 -
Previous 2 Weeks
(31 Aug 2020 to 11 Sep 2020)		 1.530 1.610 0.975 1.300 209,807,000 -
4 Weeks from
(30 Jul 2020 to 28 Aug 2020)		 0.865 1.340 0.850 1.520 941,866,300 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.